SSII News
SS Innovations International (NASDAQ: SSII) Showcases Robotic Telesurgery Capabilities at International Medical Conferences
SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were featured in successful telesurgeries during two international medical conferences in October 2026. At the European Association for Cardio-Thoracic Surgery (“EACTS”) Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir […]
Investor Brand Network
SS Innovations International (NASDAQ: SSII) Showcases Robotic Telesurgery Capabilities at International Medical Conferences
SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were featured in successful telesurgeries during two international medical conferences in October 2026. At the European Association for Cardio-Thoracic Surgery (“EACTS”) Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir […]
Investor Brand Network
SSi Falls 32% in Three Months: Should You Buy the Dip or Wait?
SSII's rising revenues and robotic surgery adoption signal growth, but widening losses and financing pressures pose challenges to profitability.
Zacks
SS Innovations International (NASDAQ: SSII) Submits FDA Response for SSi Mantra Surgical Robotic System
SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that it submitted its response to a request for additional information from the U.S. Food and Drug Administration (FDA) on Oct. 5, 2026, regarding its 510(k) submission for the SSi Mantra surgical robotic system. The response includes final data from an expanded human […]
Investor Brand Network
2 International Microcaps for Your Watchlist
SSII and IVDA have sales predominantly in India and Taiwan, respectively.
Zacks
Zacks Initiates Coverage of SSi With Neutral Recommendation
Discover why Zacks initiated coverage of SSII with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how expanding robotic surgery adoption, rising revenues and international growth are offset by persistent losses and regulatory hurdles.
Zacks
SS Innovations International (NASDAQ: SSII) Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
The growing interest in telerobotic surgery is putting SS Innovations International (NASDAQ: SSII) and its founder and CEO, cardiac surgeon Dr. Sudhir Srivastava, in an increasingly relevant part of the surgical robotics market. A recent MedTech Dive report, “Telerobotic surgery is advancing around the world. Will the US embrace it?,” examined the technology’s development and […]
Investor Brand Network
SS Innovations International (NASDAQ: SSII) Expands Robotic Cardiac Surgery Footprint with New Program at HCG Hospital in Ahmedabad
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has expanded the clinical footprint of its SSi Mantra surgical robotic system with the launch of a robotic cardiac surgery program at HCG Hospital, Mithakhali, in Ahmedabad, India. The program began with a robotic cardiac surgery LIMA take-down performed using the SSi Mantra […]
Investor Brand Network
SS Innovations International (NASDAQ: SSII) Expands Global Footprint as SSi Mantra Procedures Reach 14,103
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is reporting continued growth in the use of its SSi Mantra surgical robotic system, with the company’s installed base and procedure count increasing as it expands into new countries and surgical applications. In an update issued September 10, the company said 238 SSi […]
Investor Brand Network
SS Innovations International (NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is helping write a new chapter in Sri Lanka’s cardiac-surgery sector with the launch of the country’s first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary […]
Investor Brand Network
SS Innovations International (NASDAQ: SSII) Reports 79% Growth in SSi Mantra Procedures, Expands Global Reach
SS Innovations International (NASDAQ: SSII) provided an update on the continued expansion and utilization of its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of Sept. 8, 2026, up 79% from 7,885 at year-end 2025, while its installed base increased 42% to 238 systems from 168. The SSi Mantra is now installed across […]
Investor Brand Network